Fecal transplant for hidradenitis suppurativa: a pilot study
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests whether a fecal transplant (transferring healthy bacteria from a donor's stool into your gut) can help treat moderate to severe hidradenitis suppurativa (HS), a condition causing painful lumps under the skin. It's for people who still have flare-ups despite standard antibiotic treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have moderate (Hurley stage II) or severe (Hurley stage III) hidradenitis suppurativa
- Your HS mainly affects your armpits, breasts, or buttocks, and you currently have at least 4 inflamed spots (like nodules, abscesses, or active tunnels)
- You have had a flare-up within 3 months of finishing a standard antibiotic course (like 2–3 weeks of broad-spectrum antibiotics followed by a maintenance antibiotic)
- You are not allergic to amoxicillin-clavulanic acid (an antibiotic)
- You are not pregnant, breastfeeding, or planning to become pregnant, and you are not on another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This study tests whether a fecal microbiota transplant (a procedure that transfers healthy bacteria into your gut) can reduce inflammation and improve symptoms in people with inflammatory back pain (axial spondyloarthritis). It may help if your current treatments are not working well enough.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
This Phase 1/2 study tests whether a fecal microbiome transplant (FMT) can reduce active inflammation in people with Crohn’s disease. It’s designed for people who currently have signs of active bowel inflammation and can attend regular procedure visits.
This trial tests whether a stool (fecal) transplant from a screened donor can help remove antibiotic-resistant gut bacteria (MDRO) that keep coming back in your stool tests. It aims to reduce colonization that makes follow-up and treatment harder.
This trial tests whether transplanting stool bacteria (called fecal microbiota transplantation, or FMT) can improve symptoms in people with active ulcerative colitis. You may be able to help test a new approach for restoring gut bacteria, while receiving standard ulcerative colitis care from your doctor.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.